Several life sciences companies are currently hiring for a range of positions in San Francisco, South San Francisco, Brisbane, and San Rafael, according to a June 25 announcement. Alumis has more than a dozen roles available, including senior scientist for drug product development and senior medical director for rheumatology. GenScript is seeking a regional business development head for Northern California.
Lilly is recruiting for over a dozen positions such as discovery oncology scientific lead and scientific lead, generative AI engineer, applied intelligence for discovery. JLSa2 lists three roles in South San Francisco, including senior scientist in protein and peptide or chemical-protein conjugate formulation as well as director of GMP quality. AbbVie also has more than twelve openings in the region with positions like senior scientist I (biologics bioanalysis) and principal research scientist I (biologics screening - discovery biotherapeutics).
TegMine Therapeutics is looking to fill the role of research associate – antibody discovery and development. Maze Therapeutics has about six open roles in South San Francisco, such as senior medical director and director of biostatistics. Amgen lists over two dozen opportunities across both cities, including associate scientist in vivo pharmacology focused on cardiometabolic disorders and senior scientist specializing in computational systems and predictive biology.
IDEAYA Biosciences reports 15 live roles, including director of clinical science, principal research scientist (analytical chemistry), and director of intellectual property. Syner-G seeks candidates for three project management positions.
In Brisbane, Nurix Therapeutics offers 16 open jobs ranging from SRA protein expression to vice president of medical affairs – hematology/oncology. Mammoth BioSciences is hiring both a senior clinical scientist and a senior analyst focused on financial planning analysis.
BioMarin is hiring across multiple disciplines with 30 active postings at its location in nearby San Rafael; these include director of supply chain transformation & integration as well as pharmacovigilance associate II.
